Table 1.
Demographic, clinical and examination data of CSVD patients
| Characteristics | CSVD patients (N = 134) |
|---|---|
| Age, years, median (IQR) | 60 ± 12 |
| Sex, F/M | 55/79 |
| Height, cm, mean ± SD | 166 ± 8 |
| Weight, kg, mean ± SD | 69.8 ± 10.7 |
| BMI, kg/m2, mean ± SD | 25.3 ± 3.2 |
| Education ≥ 12 years, n (%) | 78 (58%) |
| mRS score, median (IQR) | 0 (0, 1) |
| Currently or previously smoking, n (%) | 60 (45%) |
| Hypertension, n (%) | 87 (65%) |
| Atrial fibrillation, n (%) | 3 (2%) |
| Diabetes mellitus, n (%) | 37 (28%) |
| Hyperlipidemia, n (%) | 29 (22%) |
| CSVD burden score, median (IQR) | 3 (2, 4) |
| MoCA score, median (IQR) | 20 (16, 24) |
| SPPB score, median (IQR) | 11 (9, 12) |
| Speed, m/s, mean ± SD | 0.87 ± 0.24 |
| Stride length, m, mean ± SD | 0.97 ± 0.20 |
| Stride time, s, median (IQR) | 1.12 (1.06, 1.23) |
| Support phase, %, mean ± SD | 52.7 ± 3.6 |
| Hip ROM, °, median (IQR) | 87.4 (54.3, 130.5) |
| Knee ROM, °, median (IQR) | 58.6 (51.0, 62.4) |
| Ankle ROM, °, median (IQR) | 30.5 (25.8, 34.1) |
CSVD cerebral small vessel disease; F female; M male; BMI Body Mass Index; mRS modified Rankin Scale; MoCA Montreal Cognitive Assessment; SPPB Short Physical Performance Battery; ROM range of motion; SD standard deviation; IQR interquartile range